MedTrace Logo

Acceptability of Lactacyd Femina

NCT00712868 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 559

Last updated 2009-07-20

No results posted yet for this study

Summary

To demonstrate the safety and acceptability of the gynaecological formulation.

Conditions

  • Hygiene

Interventions

DRUG

Lactic acid

Once a day

Sponsors & Collaborators

Principal Investigators

  • Judith Diaz, Md · Sanofi

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • Mexico

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00712868 on ClinicalTrials.gov